A small piece of a campus in New York that was once owned by Wyeth and then Pfizer will now become home to small drugmaker. More: RK Pharma leases part of Pfizer’s Pearl River, New York campus for manufacturing Source:
read moreNews of a second complaint filed to Indian regulators sent the drugmaker’s shares tumbling yet again, this time to their lowest point in about six years. The new complaint was said to focus on a large number of dubious transactions
read moreThe troubles for troubled Immunomedics keep piling up. The New Jersey-based biotech, which has gone through a failed tie-up deal, boardroom cleansing and FDA Form 483 issues, today reported it has received a complete response letter from the FDA related
read moreThe National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi and Mektovi combination as an option for some people with melanoma. More: NICE OK for Bravtovi skin cancer drug Source: News
read moreJohnson & Johnson’s Janssen has announced a research study using the Apple watch to help improve atrial fibrillation (AFib) outcomes, including stroke prevention, intending to to collaborate with Apple to assess the impact of the wearable technology on earlier detection
read moreUnited Neuroscience has announced a positive top-line results from the Phase IIa clinical study of UB-311 vaccine in patients with Alzheimer’s disease. More: Positive results for UB-311 Alzheimer's vaccine Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals